Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomic study of antipsychotic treatment in schizophrenia
ChiCTR-TRC-10000934Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Perphenazine, haloperidol, risperidone, olanzapine, quetiapine and 2 more in schizophrenia (7 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Reduction rate of PANSS total score. Started Jan 2009; status: completed.
02
Drugs
Perphenazinehaloperidolrisperidoneolanzapinequetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-TRC-10000934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000934.